Awarded contractOpenSuppliesCzech Republic
Dodávky léků – Tofacitinib (XELJANZ) 2023
1 supplier awarded•1 lot awarded•€2.81M awarded
Buyer: Revmatologický ústav / Praha, Czech Republic
Published Feb 12, 2024Awarded Jan 02, 2024
Antineoplastic and immunomodulating agents
Awarded value
€2.81M
Estimated value
€2.81M
Awarded at 100% of estimated value
Award date
Jan 02, 2024
Winners
1
Lots awarded
1
Winners
PHOENIX lékárenský velkoobchod, s.r.o.
1 lotPraha - Hostivař, CZE
€2.8M This contract
144 award notices•184 awarded lots•€115.08M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0001 | PHOENIX lékárenský velkoobchod, s.r.o. | €2.8M | Antineoplastic and immunomodulating agents (33652000) |